Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression prediction

Abstract Background Idiopathic Pulmonary Fibrosis (IPF) is a type of chronic interstitial pneumonia, often fatal, with elusive causes and a bleak prognosis. Its treatment options are limited and largely ineffective. Early detection and precise diagnosis are pivotal in managing the disease effectivel...

Full description

Bibliographic Details
Main Authors: Wenhua Gan, Wenwen Song, Yujuan Gao, Xuexue Zheng, Fengjuan Wang, Zirui Zhang, Ke Zen, Hongwei Liang, Xin Yan
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-024-05034-9
_version_ 1797259057577328640
author Wenhua Gan
Wenwen Song
Yujuan Gao
Xuexue Zheng
Fengjuan Wang
Zirui Zhang
Ke Zen
Hongwei Liang
Xin Yan
author_facet Wenhua Gan
Wenwen Song
Yujuan Gao
Xuexue Zheng
Fengjuan Wang
Zirui Zhang
Ke Zen
Hongwei Liang
Xin Yan
author_sort Wenhua Gan
collection DOAJ
description Abstract Background Idiopathic Pulmonary Fibrosis (IPF) is a type of chronic interstitial pneumonia, often fatal, with elusive causes and a bleak prognosis. Its treatment options are limited and largely ineffective. Early detection and precise diagnosis are pivotal in managing the disease effectively and enhancing patient survival rates. Recently, the quest for trustworthy biomarkers for IPF has gained momentum. Notably, emerging studies indicate that circular RNAs (circRNAs) found in exosomes may hold significant potential as valuable diagnostic markers. Methods In this study, we initially explored the expression profile of circRNAs in exosomes sourced from the blood of IPF patients and healthy volunteers, employing a human circRNA microarray. We then utilized RT-qPCR to corroborate the dysregulated circRNAs identified by the microarray during the training phase. Next, the circRNAs that displayed a significant increase during the training phase were selected for further validation in a larger cohort encompassing 113 IPF patients and 76 healthy volunteers. Ultimately, the expression level and function of hsa_circ_0044226 were substantiated through a series of in vivo and in vitro experiments. Results Utilizing a human circRNA microarray, we identified 11 dysregulated circRNAs in the exosomes derived from the blood of IPF patients and control volunteers. Subsequent RT-qPCR analysis revealed significant increases in three circRNAs (hsa_circ_0044226, hsa_circ_0004099, hsa_circ_0008898) within the IPF patients. Notably, hsa_circ_0044226 was markedly elevated in patients experiencing acute exacerbation of IPF (AE-IPF) compared to those with stable IPF (S-IPF). Additionally, an upregulation of hsa_circ_0044226 was observed in the blood exosomes derived from a bleomycin-induced IPF mouse model. Conclusion The expression levels of hsa_circ_0044226, hsa_circ_0004099, and hsa_circ_0008898 in plasma exosomes introduce a new paradigm of biomarkers for the diagnosis and progression of IPF.
first_indexed 2024-04-24T23:03:23Z
format Article
id doaj.art-23cb39a8e4b14806bb851643516294f1
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-04-24T23:03:23Z
publishDate 2024-03-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-23cb39a8e4b14806bb851643516294f12024-03-17T12:36:46ZengBMCJournal of Translational Medicine1479-58762024-03-0122111110.1186/s12967-024-05034-9Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression predictionWenhua Gan0Wenwen Song1Yujuan Gao2Xuexue Zheng3Fengjuan Wang4Zirui Zhang5Ke Zen6Hongwei Liang7Xin Yan8Department of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical UniversityDepartment of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical UniversityDepartment of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of China Pharmaceutical UniversityDepartment of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical UniversityDepartment of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical UniversityDepartment of Thoracic Surgery, Medical School, Nanjing Drum Tower Hospital, Nanjing UniversityDepartment of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical UniversityDepartment of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical UniversityDepartment of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of China Pharmaceutical UniversityAbstract Background Idiopathic Pulmonary Fibrosis (IPF) is a type of chronic interstitial pneumonia, often fatal, with elusive causes and a bleak prognosis. Its treatment options are limited and largely ineffective. Early detection and precise diagnosis are pivotal in managing the disease effectively and enhancing patient survival rates. Recently, the quest for trustworthy biomarkers for IPF has gained momentum. Notably, emerging studies indicate that circular RNAs (circRNAs) found in exosomes may hold significant potential as valuable diagnostic markers. Methods In this study, we initially explored the expression profile of circRNAs in exosomes sourced from the blood of IPF patients and healthy volunteers, employing a human circRNA microarray. We then utilized RT-qPCR to corroborate the dysregulated circRNAs identified by the microarray during the training phase. Next, the circRNAs that displayed a significant increase during the training phase were selected for further validation in a larger cohort encompassing 113 IPF patients and 76 healthy volunteers. Ultimately, the expression level and function of hsa_circ_0044226 were substantiated through a series of in vivo and in vitro experiments. Results Utilizing a human circRNA microarray, we identified 11 dysregulated circRNAs in the exosomes derived from the blood of IPF patients and control volunteers. Subsequent RT-qPCR analysis revealed significant increases in three circRNAs (hsa_circ_0044226, hsa_circ_0004099, hsa_circ_0008898) within the IPF patients. Notably, hsa_circ_0044226 was markedly elevated in patients experiencing acute exacerbation of IPF (AE-IPF) compared to those with stable IPF (S-IPF). Additionally, an upregulation of hsa_circ_0044226 was observed in the blood exosomes derived from a bleomycin-induced IPF mouse model. Conclusion The expression levels of hsa_circ_0044226, hsa_circ_0004099, and hsa_circ_0008898 in plasma exosomes introduce a new paradigm of biomarkers for the diagnosis and progression of IPF.https://doi.org/10.1186/s12967-024-05034-9Idiopathic pulmonary fibrosisExosomeCircular RNABiomarker
spellingShingle Wenhua Gan
Wenwen Song
Yujuan Gao
Xuexue Zheng
Fengjuan Wang
Zirui Zhang
Ke Zen
Hongwei Liang
Xin Yan
Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression prediction
Journal of Translational Medicine
Idiopathic pulmonary fibrosis
Exosome
Circular RNA
Biomarker
title Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression prediction
title_full Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression prediction
title_fullStr Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression prediction
title_full_unstemmed Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression prediction
title_short Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression prediction
title_sort exosomal circrnas in the plasma serve as novel biomarkers for ipf diagnosis and progression prediction
topic Idiopathic pulmonary fibrosis
Exosome
Circular RNA
Biomarker
url https://doi.org/10.1186/s12967-024-05034-9
work_keys_str_mv AT wenhuagan exosomalcircrnasintheplasmaserveasnovelbiomarkersforipfdiagnosisandprogressionprediction
AT wenwensong exosomalcircrnasintheplasmaserveasnovelbiomarkersforipfdiagnosisandprogressionprediction
AT yujuangao exosomalcircrnasintheplasmaserveasnovelbiomarkersforipfdiagnosisandprogressionprediction
AT xuexuezheng exosomalcircrnasintheplasmaserveasnovelbiomarkersforipfdiagnosisandprogressionprediction
AT fengjuanwang exosomalcircrnasintheplasmaserveasnovelbiomarkersforipfdiagnosisandprogressionprediction
AT ziruizhang exosomalcircrnasintheplasmaserveasnovelbiomarkersforipfdiagnosisandprogressionprediction
AT kezen exosomalcircrnasintheplasmaserveasnovelbiomarkersforipfdiagnosisandprogressionprediction
AT hongweiliang exosomalcircrnasintheplasmaserveasnovelbiomarkersforipfdiagnosisandprogressionprediction
AT xinyan exosomalcircrnasintheplasmaserveasnovelbiomarkersforipfdiagnosisandprogressionprediction